Luteinizing Hormone (LH)
Product Name | Luteinizing Hormone |
Source | Human Pituitary Glands |
Catalogue Number | 996-31 |
Purity | > 98% (SDS-PAGE) |
Form | Lyophilized |
Activity | > 8,500 IU/mg |
Contaminants | FSH: < 18.75 IU/mg (All assayed < 0.1% w/w) TSH: < 0.0425 IU/mg PRL: < 0.005 mg/mg hGH: < 0.005 mg/mg |
Formulation | Lyophilized from 50 mM ammonium bicarbonate |
Reconstitution | Reconstitute using neutral pH buffer of choice. Avoid extreme high and low pH |
Related Products | 996-11 - FSH antigen from human pituitary gland 996-21 - hGH antigen from human pituitary gland 996-51 - TSH antigen from human pituitary gland |
Storage | -20°C |
Recertification | 5 years |
Infectious Disease Testing | Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV, HBsAg, HCV NAT, HIV-1 NAT and syphilis by FDA approved methods. |
Molecular Weight | ~30,000 |
Synonyms | LH, Lutropin, Interstitial Cell-Stimulating Hormone |
References | 1) Confirmation of luteinizing hormone (LH) in living human vitreous and the effect of LH receptor reduction on murine electroretinogram, Neuroscience, June 2018. |
-
Products
- Antigens / Enzymes
- Biologicals
- Biochemicals
- Antibodies
-
Company
- Compliance
- Careers
- History
- About Us
- World Headquarters
-
Solutions
- Capabilities
- Products
- Services
-
Applications
-
Manufacturing
Research
-
Order
- How to Order
- Contact Us
- Frequent Requests